Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy

This study is currently recruiting participants.

Verified April 2013 by University of Miami Sylvester Comprehensive Cancer Center

Study NCT00450385 Information provided by University of Miami Sylvester Comprehensive Cancer Center

First Received on March 20, 2007. Last Updated on April 18, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma

Additional conditions recognized in this trial

Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse

More general conditions related to this trial

Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type

Interventions listed in this trial

Rituximab
Cyclophosphamide
Doxorubicin
Prednisone
Vincristine
RNA-based gene array studies

Additional drug interventions recognized in this trial

Antibodies
Immunoglobulin G
Immunoglobulins

Sponsors listed in this trial

University of Miami Sylvester Comprehensive Cancer Center

Back to top of Main Content